Dean Falb

Dean Falb is a Scientific Advisory Board Member at Novome Biotechnologies. Dean has also served as CSO at LogicBio Therapeutics, Founder and CTO at Synlogic, Inc., and VP R&D at Stryker Regenerative Medicine and Neogenesis (Merck). Dean Falb has also been an Entrepreneur in Residence at Atlas Ventures and a Student Advisor at Harvard i-lab.

Dean Falb has a Ph.D. in Biochemistry and Molecular Biology from Harvard University, a B.S. in Chemistry from Purdue University, and has completed an Executive Leadership Program at Harvard Business School.